<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03487471</url>
  </required_header>
  <id_info>
    <org_study_id>Elasto Trial</org_study_id>
    <nct_id>NCT03487471</nct_id>
  </id_info>
  <brief_title>Comparison of Real-time and Shear Wave Elastography</brief_title>
  <acronym>Elasto</acronym>
  <official_title>Comparison of Accuracy and Reproducibility of Breast Lesion Characterization Between Real Time Elastography and Shear Wave Elastography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tissue elasticity is being increasingly used as diagnostic parameter, since at the&#xD;
      macroscopic level benign breast lesions tend to be stiffer than normal breast tissue but&#xD;
      softer than breast cancers. Ultrasound elastography allows to probe the elasticity of breast&#xD;
      lesions in clinics. Real time elastography (RTE) and shear wave elastography (SWE) are the&#xD;
      two most widely used elastography modalities.&#xD;
&#xD;
      Assessment of breast lesions by either RTE or SWE improve the diagnostic performance of&#xD;
      standard B-mode ultrasound (US) and have the potential to assist the decision about whether&#xD;
      to perform a breast biopsy or not.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tissue elasticity is being increasingly used as diagnostic parameter, since at the&#xD;
      macroscopic level benign breast lesions tend to be stiffer than normal breast tissue but&#xD;
      softer than breast cancers. Ultrasound elastography allows to probe the elasticity of breast&#xD;
      lesions in clinics. Real time elastography (RTE) and shear wave elastography (SWE) are the&#xD;
      two most widely used elastography modalities.&#xD;
&#xD;
      Assessment of breast lesions by either RTE or SWE improve the diagnostic performance of&#xD;
      standard B-mode ultrasound (US) and have the potential to assist the decision about whether&#xD;
      to perform a breast biopsy or not. However, employing RTE and SWE using the same equipment to&#xD;
      directly compare elasticity measurements of a breast lesion has not been done. Investigators&#xD;
      propose to prospectively investigate inter-observer agreement of each modality.&#xD;
&#xD;
      The study will investigate and compare the accuracy and reproducibility of SWE and RTE in the&#xD;
      characterization of breast lesions. Furthermore, we plan to establish learning curves for RTE&#xD;
      and SWE.&#xD;
&#xD;
      In this project, investigators will compare RTE and SWE concerning their potential to&#xD;
      discriminate benign breast lesions from breast cancer. Investigators aim is to identify which&#xD;
      modality will allow clinicians the best possible patient care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assessment of dignity of breast lesion by use of real-time elastography</measure>
    <time_frame>at baseline</time_frame>
    <description>variability in breast lesion diagnostics by use of real-time elastography versus shear wave elastography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>assessment of dignity of breast lesion by use of shear wave elastography</measure>
    <time_frame>at baseline</time_frame>
    <description>variability in breast lesion diagnostics by use of real-time elastography versus shear wave elastography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Examinators learning curve</measure>
    <time_frame>baseline until year 1</time_frame>
    <description>Establish learning curves for real-time elastography and shear wave elastography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Breast Diseases</condition>
  <arm_group>
    <arm_group_label>Real-time elastography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>98 patients with breast lesion will a receive breast ultrasound (real time elastography)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shear Wave</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>98 patients with breast lesion will a receive breast ultrasound (shear wave elastography)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Real-time elastography</intervention_name>
    <description>Breast ultrasound with real-time elastography</description>
    <arm_group_label>Real-time elastography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Shear wave elastography</intervention_name>
    <description>Breast ultrasound with shear wave elastography</description>
    <arm_group_label>Shear Wave</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients at least 18 years of age with a known breast lesion&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Younger than 18 years of age&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosanna Zanetti</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Claraspital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bettina Wölnerhanssen, MD</last_name>
    <phone>0041 61 685 85 85</phone>
    <email>bettina.woelnerhanssen@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bettina Wölnerhanssen</last_name>
    <phone>0041 61 685 85 85</phone>
    <email>bettina.woelnerhanssen@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Claraspital</name>
      <address>
        <city>Basel</city>
        <zip>4016</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosanna Zanetti, MD</last_name>
      <email>Rosanna.zanetti@claraspital.ch</email>
    </contact>
    <contact_backup>
      <last_name>Bettina Wölnerhanssen, MD</last_name>
      <email>bettina.woelnerhanssen@claraspital.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Rosanna Zanetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 16, 2018</study_first_submitted>
  <study_first_submitted_qc>April 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2018</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

